Profile of brivaracetam and its potential in the treatment of epilepsy
Edoardo Ferlazzo,1,2 Emilio Russo,3 Laura Mumoli,1 Chiara Sueri,2 Sara Gasparini,1,2 Caterina Palleria,3 Angelo Labate,1 Antonio Gambardella,1 Giovambattista De Sarro,3 Umberto Aguglia1,2 1Department of Medical and Surgical Sciences, Magna Græcia University, Catanzaro, 2Regional Epilepsy...
Guardado en:
Autores principales: | Ferlazzo E, Russo E, Mumoli L, Sueri C, Gasparini S, Palleria C, Labate A, Gambardella A, De Sarro G, Aguglia U |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7c8762e00d1b4a2985a2f631eeb0daef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Monotherapy for partial epilepsy: focus on levetiracetam
por: Antonio Gambardella, et al.
Publicado: (2008) -
Brivaracetam in the treatment of epilepsy: a review of clinical trial data
por: Feyissa AM
Publicado: (2019) -
Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
por: L. Abraira, et al.
Publicado: (2021) -
Response: Sotos Syndrome and the added value of genetic workup in epilepsy surgery
por: Kenneth A. Myers
Publicado: (2021) -
Sotos syndrome and the added value of genetic workup in epilepsy surgery
por: Linda Bättig, et al.
Publicado: (2021)